Gut diseases such as inflammatory bowel disease (IBD) are increasingly prevalent worldwide, especially in industrialised countries. In 2015 alone, 250,000 people in the UK were diagnosed with IBD, and 3 million in the United States (1, 2). Symptoms can include pain and swelling of the stomach, bloody diarrhoea, weight loss and extreme tiredness.
A new study in Experimental Physiology proposes a novel, non-invasive test for assessing gut function that may help screen and monitor treatment of gut diseases using only a small sample (1 mL) of blood and stool. How well your gut functions is determined by the gut-blood barrier , a complex multi-layer system. This can be compared to a fine-tuned filter that precisely controls the passage of nutrients and prevents bacteria passing from inside the bowel into the bloodstream.
In those with IBD, and other intestinal diseases, the gut-blood barrier is impaired. Here the intestinal wall is more like a ripped sieve, allowing more bacterial products to pass from the gut into the blood. This is commonly referred to as a leaky gut.
This test measures the concentration of gut bacterial products (produced by bacteria during metabolism) in the patient’s blood and stool. The authors believe that with further research this assessment of gut leakage will be very important in the diagnosis and treatment of IBD and other intestinal diseases.
The usual strategy for diagnosing and monitoring IBD is based on a colonoscopy, which is invasive, often requires anaesthesia, and assesses structural lesions, rather than gut malfunction. Gut disorders can happen before there are visible structural changes, so diagnosing based on functional tests evaluating gut leakage could allow clinicians to detect the disease earlier. While there is no cure for IBD, it is controllable. Early diagnosis would enable patients to control symptoms before they became severe, improving their quality of life.
This new research provides a non-invasive, simple test that could not only be useful for diagnosing IBD, but also other gut disorders, such as celiac disease and food allergies. It’s also helpful for detecting diseases that result in a leaky gut, such as heart failure, high blood pressure and liver ailments.
Marcin Ufnal, senior author on the study said:
“This may be a very important tool for diagnosis and treatment of gut and other diseases, using the leaky gut as a marker for disease, as well as a potential target for treatment. “
Learn more: New, non-invasive test for bowel diseases
The Latest on: Gut diseases
via Google News
The Latest on: Gut diseases
- Research shows even animals benefit from social distance to prevent diseaseon May 11, 2020 at 1:28 am
Microorganisms living inside and on our body play a crucial role in both the maintenance of our health and the development of disease. Now researchers at UTSA have uncovered evidence about the ...
- We All Want To Improve Our Gut Health. But How Do We Know What Works?on May 7, 2020 at 6:57 am
The Gut Intelligence Test from Viome will figure out how the microbes in your gut impact your health AND tell you what you can do about it. Futurism fans: To create this content, a non-editorial team ...
- Meet the ‘psychobiome’: the gut bacteria that may alter how you think, feel, and acton May 7, 2020 at 6:11 am
Scientists hope to turn gut microbes or their products into new antidepressants or drugs for other brain disorders ...
- Cholesterol lowering drugs can improve composition of gut bacteria in obese individualson May 7, 2020 at 5:19 am
The human gut microbiota consists of trillions of bacteria, fungi and virus constituting an inner chemical factory producing a multitude of microbial compounds affecting immunity, neurobiology and ...
- Worried about coronavirus? Pay attention to your guton May 7, 2020 at 2:59 am
COVID-19 can attack your gastrointestinal tract, and those with symptoms such as diarrhoea, nausea and vomiting may have a worse version of the disease.
- Heart Drugs May Influence Gut Microbiome In Obese People, Says New Studyon May 6, 2020 at 9:15 am
Researchers have found that a particular combination of bacteria in the gut microbiome known to be associated with inflammation is more prevalent in obese people. However, this was not the case for ...
- Obese people who take statins to manage their cholesterol are LESS likely to have harmful gut bacteria linked to bowel disease, study findson May 6, 2020 at 9:07 am
Researchers from Belgium found statins destroy bad gut bacteria that fuel cardiovascular disease and bowel cancer and are often found in obese people.
- Statin drugs might boost healthy gut microbeson May 6, 2020 at 8:06 am
An analysis of faecal samples reveals that obese people who take cholesterol-lowering statin drugs have a ‘healthier’ community of gut microorganisms than would be expected. What are the implications ...
- Obesity is linked to gut microbiota disturbance, but not among statin-treated individualson May 6, 2020 at 8:01 am
In 2012, the European Union MetaCardis consortium, comprising 14 research groups from six European countries with multidisciplinary expertise set out to investigate a potential role of the gut ...
- Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese maleson May 5, 2020 at 2:28 am
A growing body of evidence suggests that the human gut microbiota plays a role in the development of obesity and related metabolic diseases. However, there is little consensus bet ...
via Bing News